Systematic Reviews and Meta-Analysis Multiple systematic reviews and meta-analyses have evaluated the efficacy and safety of oral 600 mg/day ALA in treating DPN, showing significant improvements in neuropathic pain and NCV [110]
it applies to how our brain functions, how our heart performs, and how much energy we have to play with our children or grandchildren
Starting at a lower dose allows tissues to respond without overstimulation, then the higher dose in Phase 2 extends and deepens that response
N-acetylcysteine is a mucolytic drug which exhibits antioxidant and anti-inflammatory effects
In the future, high-quality research needs to be further carried out to clarify its clinical positioning and safety, so as to promote its rational application in digestive system diseases
However, for methane SIBO associated with constipation, reducing fiber will often exacerbate constipation